St. Louis Personal Injury Attorney & Workers Compensation Lawyer
 

« THE VALUE OF MISSOURI CAR ACCIDENT SETTLEMENTS AND HERNIATED DISCS | Main | OUR LAWYERS ARE INVESTIGATING CASES OF TARDIVE DYSKINESIA CAUSED BY REGLAN »

New Press Release Issued By Our Missouri Reglan Tardive Dyskinesia Lawyers

Recently, our Tardive Dyskinesia Lawyers have issued a new Reglan Tardive Dyskinesia Press Release.  The Federal Food and Drug Administration has issued a mandate requiring the makers of Reglan (Scharz Pharma, Inc) to include a black box warning on the labels of Reglan warning of the probability that it may cause Tardive Dyskinesia.  This is a very serious condition that is permanent and cause extreme problems.  Notably, the makers of Reglan did not voluntarily issue this warning when Reglan was first put on the market.  Thus, our Reglan Side Effect Attorneys believe that, if a large pharmaceutical company is going to market a drug that causes such a permanent condition, they should be responsible for the harm they cause. 

We are seeking to speak with anyone across the country who had developed Tardive Dyskinesia subsequent to taking to Reglan.  It is always free to talk about your situation.  You can reach our lawyers toll free at 888-956-2487.  Although headquartered in St. Louis, MO, we are not only speaking to individuals in Missouri and Illinois, but across the entire country. 

Post a comment

(If you haven't left a comment here before, you may need to be approved by the site owner before your comment will appear. Until then, it won't appear on the entry. Thanks for waiting.)



St. Louis Personal Injury & Worker's Compensation Attorney

Attorney Web Design The information on this St. Louis Personal Injury & Workers Compensation Attorneys / Law Firm Blog is for general information purposes only. Nothing on this or associated pages, documents, comments, answers, emails, or other communications should be taken as legal advice for any individual case or situation. This information on this website is not intended to create, and receipt or viewing of this information does not constitute, an attorney-client relationship.